GEN Exclusives

More »

GEN Poll

More »
Jan 06, 2014

Wall Street Winners

GEN recently published a list of the top 10 Wall Street Winners of 2013–the ten best stock performers of the year in biotech, pharma, tools/tech, and services (CROs). Which of the companies on our list do you think is most likely to remain victorious on Wall Street?

Which of our Top 10 Wall Street Winners of 2013 do you think is most likely to keep increasing in value?

Acadia Pharmaceuticals
 
  24.5%
BioCryst Pharmaceuticals
 
  8.5%
Catalyst Pharmaceutical Partners
 
  7.5%
Galectin Therapeutics
 
  9.4%
Gentium
 
  10.4%
Idera Pharmaceuticals
 
  8.5%
Insys Therapeutics
 
  8.5%
Keryx Biopharmaceuticals
 
  4.7%
Prothena
 
  5.7%
Puma Biotechnology
 
  12.3%

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Cancer Drug Approvals and Efficacy

Do you think regulatory agencies should be required to provide stronger evidence of the clinical effectiveness of cancer drugs, including a greater emphasis on patient survival time?

More »